BIOGY

Healthcare Drug Manufacturers - Specialty & Generic

BioGaia AB (publ)

$12.45
-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap
1.26B
Avg Volume
15
P/E (TTM)
33.65
EPS
$0.37
52W High
$12.45
52W Low
$9.64
Div. Yield
0.0%

Valuation

P/B Ratio
1.03

Margins

Gross Margin 73.0%
Operating Margin 0.0%
Net Margin 22.0%
EBITDA Margin 28.8%

Growth & Returns

Revenue Growth (YoY)
8.9%
Earnings Growth (YoY)
17.4%
Earnings Growth (QoQ)
17.4%
Return on Equity
30.8%
Return on Assets
19.8%

Liquidity & Leverage

Current Ratio
4.44
Quick Ratio
2.11

About

BioGaia AB (publ), a healthcare company, develops, manufactures, markets and sells probiotic products for gut, oral, and immune health in Europe, the Middle East, Africa, the United States, the Asia-Pacific, Australia, and New Zealand. It operates through Pediatrics, Adult Health, and Other segments. The Pediatrics segment offers drops, oral rehydration solutions, and gut health tablets, as well as cultures that are used as an ingredient in infant formula and milk formula. Its Adult Health segment provides gut health tablets, bone health tablets, and oral health lozenges, as well as cultures, which are used as an ingredient in a licensee's dairy product. The Other segment offers packaging solutions. It sells its products through distribution partners or through its own distribution channels. The company was incorporated in 1990 and is headquartered in Stockholm, Sweden.

www.biogaiagroup.com